Report Categories
View AllRecent Articles
View All
NAGE Niagen Bioscience Inc reports solid Q4 2025 EPS beat and nearly 30 percent year over year revenue growth stock rises modestly
Everpure PSTG Portfolio Impact Q1 2026 Earnings Beat Estimates
BY Byline Bancorp Inc reports slight Q4 2025 earnings beat slips 015 percent in regular trading today
The margin expansion playbook at First FUNC Q1 2026 EPS Exceeds Expectations
Shoulder Innovations SI Crushes Q1 2026 Estimates EPS 041 Tops Views
Ares Capital ARCC Q1 2026 Results Miss Estimates EPS 047 vs 049
Sutro Biopharma STRO Q1 2026 Earnings EPS 294 Beats Estimates
Global Markets Navigate Iran Conflict and AI Optimism G7 Talks and Nvidia Earnings in Focus
Colliers International CIGI Holds Steady Near 96 Amid Low Volume and Sector Pressures
Vor Biopharma Surges 546 as Buyers Defend Key Support Level VOR
Cohen Steers REIT and Preferred Income Fund RNP Stabilizes Near 2080 as Market Digests Modest Decline
JFB Construction Holdings JFB Slides 226 as Selling Pressure Tests 519 Level